The global Enterovirus Vaccine market is projected to grow from US$ 344 million in 2024 to US$ 482.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.

Enterovirus Vaccine Market

Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Enterovirus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Enterovirus Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Enterovirus Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enterovirus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Enterovirus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Enterovirus Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Enterovirus Vaccine Market Report

Report Metric	Details
Report Name	Enterovirus Vaccine Market
Accounted market size in 2024	US$ 344 million
Forecasted market size in 2030	US$ 482.5 million
CAGR	5.8
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Coxasckievirus A Coxasckievirus B Human Enterovirus 71 Others
Segment by Application	Hospital Research Institute Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology, Beijing Minhai Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Enterovirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enterovirus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Enterovirus Vaccine Market growing?

Ans: The Enterovirus Vaccine Market witnessing a CAGR of 5.8 during the forecast period 2024-2030.

What is the Enterovirus Vaccine Market size in 2030?

Ans: The Enterovirus Vaccine Market size in 2030 will be US$ 482.5 million.

Who are the main players in the Enterovirus Vaccine Market report?

Ans: The main players in the Enterovirus Vaccine Market are Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology, Beijing Minhai Biotechnology

What are the Application segmentation covered in the Enterovirus Vaccine Market report?

Ans: The Applications covered in the Enterovirus Vaccine Market report are Hospital, Research Institute, Others

What are the Type segmentation covered in the Enterovirus Vaccine Market report?

Ans: The Types covered in the Enterovirus Vaccine Market report are Coxasckievirus A, Coxasckievirus B, Human Enterovirus 71, Others

1 Study Coverage

1.1 Enterovirus Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Enterovirus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Coxasckievirus A

1.2.3 Coxasckievirus B

1.2.4 Human Enterovirus 71

1.2.5 Others

1.3 Market by Application

1.3.1 Global Enterovirus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Research Institute

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Enterovirus Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Enterovirus Vaccine Revenue by Region

2.2.1 Global Enterovirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Enterovirus Vaccine Revenue by Region (2019-2024)

2.2.3 Global Enterovirus Vaccine Revenue by Region (2025-2030)

2.2.4 Global Enterovirus Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Enterovirus Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Enterovirus Vaccine Sales by Region

2.4.1 Global Enterovirus Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Enterovirus Vaccine Sales by Region (2019-2024)

2.4.3 Global Enterovirus Vaccine Sales by Region (2025-2030)

2.4.4 Global Enterovirus Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Enterovirus Vaccine Sales by Manufacturers

3.1.1 Global Enterovirus Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Enterovirus Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Enterovirus Vaccine in 2023

3.2 Global Enterovirus Vaccine Revenue by Manufacturers

3.2.1 Global Enterovirus Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Enterovirus Vaccine Revenue in 2023

3.3 Global Key Players of Enterovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Enterovirus Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Enterovirus Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Enterovirus Vaccine Sales by Type

4.1.1 Global Enterovirus Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Enterovirus Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Enterovirus Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Enterovirus Vaccine Revenue by Type

4.2.1 Global Enterovirus Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Enterovirus Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Enterovirus Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Enterovirus Vaccine Price by Type

4.3.1 Global Enterovirus Vaccine Price by Type (2019-2024)

4.3.2 Global Enterovirus Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Enterovirus Vaccine Sales by Application

5.1.1 Global Enterovirus Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Enterovirus Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Enterovirus Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Enterovirus Vaccine Revenue by Application

5.2.1 Global Enterovirus Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Enterovirus Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Enterovirus Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Enterovirus Vaccine Price by Application

5.3.1 Global Enterovirus Vaccine Price by Application (2019-2024)

5.3.2 Global Enterovirus Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Enterovirus Vaccine Market Size by Type

6.1.1 US & Canada Enterovirus Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Enterovirus Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Enterovirus Vaccine Market Size by Application

6.2.1 US & Canada Enterovirus Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Enterovirus Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Enterovirus Vaccine Market Size by Country

6.3.1 US & Canada Enterovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Enterovirus Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Enterovirus Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Enterovirus Vaccine Market Size by Type

7.1.1 Europe Enterovirus Vaccine Sales by Type (2019-2030)

7.1.2 Europe Enterovirus Vaccine Revenue by Type (2019-2030)

7.2 Europe Enterovirus Vaccine Market Size by Application

7.2.1 Europe Enterovirus Vaccine Sales by Application (2019-2030)

7.2.2 Europe Enterovirus Vaccine Revenue by Application (2019-2030)

7.3 Europe Enterovirus Vaccine Market Size by Country

7.3.1 Europe Enterovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Enterovirus Vaccine Sales by Country (2019-2030)

7.3.3 Europe Enterovirus Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Enterovirus Vaccine Market Size

8.1.1 China Enterovirus Vaccine Sales (2019-2030)

8.1.2 China Enterovirus Vaccine Revenue (2019-2030)

8.2 China Enterovirus Vaccine Market Size by Application

8.2.1 China Enterovirus Vaccine Sales by Application (2019-2030)

8.2.2 China Enterovirus Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Enterovirus Vaccine Market Size by Type

9.1.1 Asia Enterovirus Vaccine Sales by Type (2019-2030)

9.1.2 Asia Enterovirus Vaccine Revenue by Type (2019-2030)

9.2 Asia Enterovirus Vaccine Market Size by Application

9.2.1 Asia Enterovirus Vaccine Sales by Application (2019-2030)

9.2.2 Asia Enterovirus Vaccine Revenue by Application (2019-2030)

9.3 Asia Enterovirus Vaccine Sales by Region

9.3.1 Asia Enterovirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Enterovirus Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Enterovirus Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Enterovirus Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Enterovirus Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sinovac Biotech

11.1.1 Sinovac Biotech Company Information

11.1.2 Sinovac Biotech Overview

11.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Sinovac Biotech Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sinovac Biotech Recent Developments

11.2 Medigen Vaccine Biologics

11.2.1 Medigen Vaccine Biologics Company Information

11.2.2 Medigen Vaccine Biologics Overview

11.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Medigen Vaccine Biologics Recent Developments

11.3 Shenzhen Neptunus

11.3.1 Shenzhen Neptunus Company Information

11.3.2 Shenzhen Neptunus Overview

11.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Shenzhen Neptunus Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Shenzhen Neptunus Recent Developments

11.4 Sinopharm

11.4.1 Sinopharm Company Information

11.4.2 Sinopharm Overview

11.4.3 Sinopharm Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Sinopharm Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sinopharm Recent Developments

11.5 Adimmune

11.5.1 Adimmune Company Information

11.5.2 Adimmune Overview

11.5.3 Adimmune Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Adimmune Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Adimmune Recent Developments

11.6 Intravacc

11.6.1 Intravacc Company Information

11.6.2 Intravacc Overview

11.6.3 Intravacc Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Intravacc Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Intravacc Recent Developments

11.7 Shanghai Zerun Biotechnology

11.7.1 Shanghai Zerun Biotechnology Company Information

11.7.2 Shanghai Zerun Biotechnology Overview

11.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Shanghai Zerun Biotechnology Recent Developments

11.8 Beijing Minhai Biotechnology

11.8.1 Beijing Minhai Biotechnology Company Information

11.8.2 Beijing Minhai Biotechnology Overview

11.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Beijing Minhai Biotechnology Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Enterovirus Vaccine Industry Chain Analysis

12.2 Enterovirus Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Enterovirus Vaccine Production Mode & Process

12.4 Enterovirus Vaccine Sales and Marketing

12.4.1 Enterovirus Vaccine Sales Channels

12.4.2 Enterovirus Vaccine Distributors

12.5 Enterovirus Vaccine Customers

13 Market Dynamics

13.1 Enterovirus Vaccine Industry Trends

13.2 Enterovirus Vaccine Market Drivers

13.3 Enterovirus Vaccine Market Challenges

13.4 Enterovirus Vaccine Market Restraints

14 Key Findings in The Global Enterovirus Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Beijing Minhai Biotechnology

Medigen Vaccine Biologics

Shenzhen Neptunus

Shanghai Zerun Biotechnology

List of Tables

Table 1. Global Enterovirus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Coxasckievirus A

Table 3. Major Manufacturers of Coxasckievirus B

Table 4. Major Manufacturers of Human Enterovirus 71

Table 5. Major Manufacturers of Others

Table 6. Global Enterovirus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Enterovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Enterovirus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Enterovirus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Enterovirus Vaccine Revenue Market Share by Region (2019-2024)

Table 11. Global Enterovirus Vaccine Revenue Market Share by Region (2025-2030)

Table 12. Global Enterovirus Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Enterovirus Vaccine Sales by Region (2019-2024) & (K Doses)

Table 14. Global Enterovirus Vaccine Sales by Region (2025-2030) & (K Doses)

Table 15. Global Enterovirus Vaccine Sales Market Share by Region (2019-2024)

Table 16. Global Enterovirus Vaccine Sales Market Share by Region (2025-2030)

Table 17. Global Enterovirus Vaccine Sales by Manufacturers (2019-2024) & (K Doses)

Table 18. Global Enterovirus Vaccine Sales Share by Manufacturers (2019-2024)

Table 19. Global Enterovirus Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Enterovirus Vaccine Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Enterovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Enterovirus Vaccine Price by Manufacturers 2019-2024 (US$/Dose)

Table 23. Global Enterovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Enterovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2023)

Table 25. Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Enterovirus Vaccine, Product Offered and Application

Table 27. Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Enterovirus Vaccine Sales by Type (2019-2024) & (K Doses)

Table 30. Global Enterovirus Vaccine Sales by Type (2025-2030) & (K Doses)

Table 31. Global Enterovirus Vaccine Sales Share by Type (2019-2024)

Table 32. Global Enterovirus Vaccine Sales Share by Type (2025-2030)

Table 33. Global Enterovirus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Enterovirus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Enterovirus Vaccine Revenue Share by Type (2019-2024)

Table 36. Global Enterovirus Vaccine Revenue Share by Type (2025-2030)

Table 37. Enterovirus Vaccine Price by Type (2019-2024) & (US$/Dose)

Table 38. Global Enterovirus Vaccine Price Forecast by Type (2025-2030) & (US$/Dose)

Table 39. Global Enterovirus Vaccine Sales by Application (2019-2024) & (K Doses)

Table 40. Global Enterovirus Vaccine Sales by Application (2025-2030) & (K Doses)

Table 41. Global Enterovirus Vaccine Sales Share by Application (2019-2024)

Table 42. Global Enterovirus Vaccine Sales Share by Application (2025-2030)

Table 43. Global Enterovirus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Enterovirus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Enterovirus Vaccine Revenue Share by Application (2019-2024)

Table 46. Global Enterovirus Vaccine Revenue Share by Application (2025-2030)

Table 47. Enterovirus Vaccine Price by Application (2019-2024) & (US$/Dose)

Table 48. Global Enterovirus Vaccine Price Forecast by Application (2025-2030) & (US$/Dose)

Table 49. US & Canada Enterovirus Vaccine Sales by Type (2019-2024) & (K Doses)

Table 50. US & Canada Enterovirus Vaccine Sales by Type (2025-2030) & (K Doses)

Table 51. US & Canada Enterovirus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Enterovirus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Enterovirus Vaccine Sales by Application (2019-2024) & (K Doses)

Table 54. US & Canada Enterovirus Vaccine Sales by Application (2025-2030) & (K Doses)

Table 55. US & Canada Enterovirus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Enterovirus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Enterovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Enterovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Enterovirus Vaccine Sales by Country (2019-2024) & (K Doses)

Table 61. US & Canada Enterovirus Vaccine Sales by Country (2025-2030) & (K Doses)

Table 62. Europe Enterovirus Vaccine Sales by Type (2019-2024) & (K Doses)

Table 63. Europe Enterovirus Vaccine Sales by Type (2025-2030) & (K Doses)

Table 64. Europe Enterovirus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Enterovirus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Enterovirus Vaccine Sales by Application (2019-2024) & (K Doses)

Table 67. Europe Enterovirus Vaccine Sales by Application (2025-2030) & (K Doses)

Table 68. Europe Enterovirus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Enterovirus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Enterovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Enterovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Enterovirus Vaccine Sales by Country (2019-2024) & (K Doses)

Table 74. Europe Enterovirus Vaccine Sales by Country (2025-2030) & (K Doses)

Table 75. China Enterovirus Vaccine Sales by Type (2019-2024) & (K Doses)

Table 76. China Enterovirus Vaccine Sales by Type (2025-2030) & (K Doses)

Table 77. China Enterovirus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Enterovirus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Enterovirus Vaccine Sales by Application (2019-2024) & (K Doses)

Table 80. China Enterovirus Vaccine Sales by Application (2025-2030) & (K Doses)

Table 81. China Enterovirus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Enterovirus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Enterovirus Vaccine Sales by Type (2019-2024) & (K Doses)

Table 84. Asia Enterovirus Vaccine Sales by Type (2025-2030) & (K Doses)

Table 85. Asia Enterovirus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Enterovirus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Enterovirus Vaccine Sales by Application (2019-2024) & (K Doses)

Table 88. Asia Enterovirus Vaccine Sales by Application (2025-2030) & (K Doses)

Table 89. Asia Enterovirus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Enterovirus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Enterovirus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Enterovirus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Enterovirus Vaccine Sales by Region (2019-2024) & (K Doses)

Table 95. Asia Enterovirus Vaccine Sales by Region (2025-2030) & (K Doses)

Table 96. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2019-2024) & (K Doses)

Table 97. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Type (2025-2030) & (K Doses)

Table 98. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2019-2024) & (K Doses)

Table 101. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Application (2025-2030) & (K Doses)

Table 102. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Enterovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2019-2024) & (K Doses)

Table 108. Middle East, Africa and Latin America Enterovirus Vaccine Sales by Country (2025-2030) & (K Doses)

Table 109. Sinovac Biotech Company Information

Table 110. Sinovac Biotech Description and Major Businesses

Table 111. Sinovac Biotech Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 112. Sinovac Biotech Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Sinovac Biotech Recent Developments

Table 114. Medigen Vaccine Biologics Company Information

Table 115. Medigen Vaccine Biologics Description and Major Businesses

Table 116. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 117. Medigen Vaccine Biologics Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Medigen Vaccine Biologics Recent Developments

Table 119. Shenzhen Neptunus Company Information

Table 120. Shenzhen Neptunus Description and Major Businesses

Table 121. Shenzhen Neptunus Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 122. Shenzhen Neptunus Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Shenzhen Neptunus Recent Developments

Table 124. Sinopharm Company Information

Table 125. Sinopharm Description and Major Businesses

Table 126. Sinopharm Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 127. Sinopharm Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Sinopharm Recent Developments

Table 129. Adimmune Company Information

Table 130. Adimmune Description and Major Businesses

Table 131. Adimmune Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 132. Adimmune Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Adimmune Recent Developments

Table 134. Intravacc Company Information

Table 135. Intravacc Description and Major Businesses

Table 136. Intravacc Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 137. Intravacc Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Intravacc Recent Developments

Table 139. Shanghai Zerun Biotechnology Company Information

Table 140. Shanghai Zerun Biotechnology Description and Major Businesses

Table 141. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 142. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Shanghai Zerun Biotechnology Recent Developments

Table 144. Beijing Minhai Biotechnology Company Information

Table 145. Beijing Minhai Biotechnology Description and Major Businesses

Table 146. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 147. Beijing Minhai Biotechnology Enterovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Beijing Minhai Biotechnology Recent Developments

Table 149. Key Raw Materials Lists

Table 150. Raw Materials Key Suppliers Lists

Table 151. Enterovirus Vaccine Distributors List

Table 152. Enterovirus Vaccine Customers List

Table 153. Enterovirus Vaccine Market Trends

Table 154. Enterovirus Vaccine Market Drivers

Table 155. Enterovirus Vaccine Market Challenges

Table 156. Enterovirus Vaccine Market Restraints

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Enterovirus Vaccine Product Picture

Figure 2. Global Enterovirus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Enterovirus Vaccine Market Share by Type in 2023 & 2030

Figure 4. Coxasckievirus A Product Picture

Figure 5. Coxasckievirus B Product Picture

Figure 6. Human Enterovirus 71 Product Picture

Figure 7. Others Product Picture

Figure 8. Global Enterovirus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Enterovirus Vaccine Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Research Institute

Figure 12. Others

Figure 13. Enterovirus Vaccine Report Years Considered

Figure 14. Global Enterovirus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Enterovirus Vaccine Revenue 2019-2030 (US$ Million)

Figure 16. Global Enterovirus Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Enterovirus Vaccine Revenue Market Share by Region (2019-2030)

Figure 18. Global Enterovirus Vaccine Sales 2019-2030 ((K Doses)

Figure 19. Global Enterovirus Vaccine Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Enterovirus Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 21. US & Canada Enterovirus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Enterovirus Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 23. Europe Enterovirus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Enterovirus Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 25. China Enterovirus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Enterovirus Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 27. Asia (excluding China) Enterovirus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Enterovirus Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 29. Middle East, Africa and Latin America Enterovirus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 30. The Enterovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. The Top 5 and 10 Largest Manufacturers of Enterovirus Vaccine in the World: Market Share by Enterovirus Vaccine Revenue in 2023

Figure 32. Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 33. Global Enterovirus Vaccine Sales Market Share by Type (2019-2030)

Figure 34. Global Enterovirus Vaccine Revenue Market Share by Type (2019-2030)

Figure 35. Global Enterovirus Vaccine Sales Market Share by Application (2019-2030)

Figure 36. Global Enterovirus Vaccine Revenue Market Share by Application (2019-2030)

Figure 37. US & Canada Enterovirus Vaccine Sales Market Share by Type (2019-2030)

Figure 38. US & Canada Enterovirus Vaccine Revenue Market Share by Type (2019-2030)

Figure 39. US & Canada Enterovirus Vaccine Sales Market Share by Application (2019-2030)

Figure 40. US & Canada Enterovirus Vaccine Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Enterovirus Vaccine Revenue Share by Country (2019-2030)

Figure 42. US & Canada Enterovirus Vaccine Sales Share by Country (2019-2030)

Figure 43. U.S. Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 44. Canada Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 45. Europe Enterovirus Vaccine Sales Market Share by Type (2019-2030)

Figure 46. Europe Enterovirus Vaccine Revenue Market Share by Type (2019-2030)

Figure 47. Europe Enterovirus Vaccine Sales Market Share by Application (2019-2030)

Figure 48. Europe Enterovirus Vaccine Revenue Market Share by Application (2019-2030)

Figure 49. Europe Enterovirus Vaccine Revenue Share by Country (2019-2030)

Figure 50. Europe Enterovirus Vaccine Sales Share by Country (2019-2030)

Figure 51. Germany Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. France Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. U.K. Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 54. Italy Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 55. Russia Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 56. China Enterovirus Vaccine Sales Market Share by Type (2019-2030)

Figure 57. China Enterovirus Vaccine Revenue Market Share by Type (2019-2030)

Figure 58. China Enterovirus Vaccine Sales Market Share by Application (2019-2030)

Figure 59. China Enterovirus Vaccine Revenue Market Share by Application (2019-2030)

Figure 60. Asia Enterovirus Vaccine Sales Market Share by Type (2019-2030)

Figure 61. Asia Enterovirus Vaccine Revenue Market Share by Type (2019-2030)

Figure 62. Asia Enterovirus Vaccine Sales Market Share by Application (2019-2030)

Figure 63. Asia Enterovirus Vaccine Revenue Market Share by Application (2019-2030)

Figure 64. Asia Enterovirus Vaccine Revenue Share by Region (2019-2030)

Figure 65. Asia Enterovirus Vaccine Sales Share by Region (2019-2030)

Figure 66. Japan Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. South Korea Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. China Taiwan Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 69. Southeast Asia Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 70. India Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 71. Middle East, Africa and Latin America Enterovirus Vaccine Sales Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Enterovirus Vaccine Sales Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Enterovirus Vaccine Revenue Share by Country (2019-2030)

Figure 76. Middle East, Africa and Latin America Enterovirus Vaccine Sales Share by Country (2019-2030)

Figure 77. Brazil Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. Mexico Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. Turkey Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 80. Israel Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 81. GCC Countries Enterovirus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 82. Enterovirus Vaccine Value Chain

Figure 83. Enterovirus Vaccine Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions